Cargando…

Significant Efficacy of a Single Low Dose of Primaquine Compared to Stand-Alone Artemisinin Combination Therapy in Reducing Gametocyte Carriage in Cambodian Patients with Uncomplicated Multidrug-Resistant Plasmodium falciparum Malaria

Since 2012, a single low dose of primaquine (SLDPQ; 0.25 mg/kg of body weight) with artemisinin-based combination therapies has been recommended as the first-line treatment of acute uncomplicated Plasmodium falciparum malaria to interrupt its transmission, especially in low-transmission settings of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vantaux, Amélie, Kim, Saorin, Piv, Eakpor, Chy, Sophy, Berne, Laura, Khim, Nimol, Lek, Dysoley, Siv, Sovannaroth, Mukaka, Mavuto, Taylor, Walter R., Ménard, Didier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2020
Materias:	Epidemiology and Surveillance
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269483/ https://www.ncbi.nlm.nih.gov/pubmed/32179526 http://dx.doi.org/10.1128/AAC.02108-19

Ejemplares similares

The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians
por: Dysoley, Lek, et al.
Publicado: (2019)

Anopheles ecology, genetics and malaria transmission in northern Cambodia
por: Vantaux, Amélie, et al.
Publicado: (2021)

Publisher Correction: Anopheles ecology, genetics and malaria transmission in northern Cambodia
por: Vantaux, Amélie, et al.
Publicado: (2021)

Novel Cross-Border Approaches to Optimise Identification of Asymptomatic and Artemisinin-Resistant Plasmodium Infection in Mobile Populations Crossing Cambodian Borders
por: Edwards, Hannah M., et al.
Publicado: (2015)

G6PD deficiency in Plasmodium falciparum and Plasmodium vivax malaria-infected Cambodian patients
por: Khim, Nimol, et al.
Publicado: (2013)

Complexity of Infection and Genetic Diversity in Cambodian Plasmodium vivax
por: Friedrich, Lindsey R., et al.
Publicado: (2016)

Therapeutic and Transmission-Blocking  Efficacy of Dihydroartemisinin/Piperaquine and Chloroquine against Plasmodium vivax Malaria, Cambodia
por: Popovici, Jean, et al.
Publicado: (2018)

Performance of “VIKIA Malaria Ag Pf/Pan” (IMACCESS®), a new malaria rapid diagnostic test for detection of symptomatic malaria infections
por: Chou, Monidarin, et al.
Publicado: (2012)

Field Trial Evaluation of the Performances of Point-of-Care Tests for Screening G6PD Deficiency in Cambodia
por: Roca-Feltrer, Arantxa, et al.
Publicado: (2014)

Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency
por: Taylor, Walter R J, et al.
Publicado: (2019)

Corrigendum to: Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency
por: Taylor, Walter R J, et al.
Publicado: (2020)

Prevalence and characterization of piperaquine, mefloquine and artemisinin derivatives triple-resistant Plasmodium falciparum in Cambodia
por: Mairet-Khedim, Mélissa, et al.
Publicado: (2022)

Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations
por: Duru, Valentine, et al.
Publicado: (2015)

Prevalence of K13 mutation and Day-3 positive parasitaemia in artemisinin-resistant malaria endemic area of Cambodia: a cross-sectional study
por: Kheang, Soy Ty, et al.
Publicado: (2017)

Forest malaria in Cambodia: the occupational and spatial clustering of Plasmodium vivax and Plasmodium falciparum infection risk in a cross-sectional survey in Mondulkiri province, Cambodia
por: Sandfort, Mirco, et al.
Publicado: (2020)

Plasmodium prevalence and artemisinin-resistant falciparum malaria in Preah Vihear Province, Cambodia: a cross-sectional population-based study
por: Bosman, Philippe, et al.
Publicado: (2014)

Correction to: Prevalence of K13 mutation and Day-3 positive parasitaemia in artemisinin-resistant malaria endemic area of Cambodia: a cross-sectional study
por: Kheang, Soy Ty, et al.
Publicado: (2017)

Plasmodium falciparum parasite population structure and gene flow associated to anti-malarial drugs resistance in Cambodia
por: Dwivedi, Ankit, et al.
Publicado: (2016)

Establishing research priorities for malaria elimination in the context of the emergency response to artemisinin resistance framework-the Cambodian approach
por: Canavati, Sara E., et al.
Publicado: (2016)

Reactive case-detection of malaria in Pailin Province, Western Cambodia: lessons from a year-long evaluation in a pre-elimination setting
por: Hustedt, John, et al.
Publicado: (2016)

Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria
por: Taylor, Walter R. J., et al.
Publicado: (2021)

Choosing interventions to eliminate forest malaria: preliminary results of two operational research studies inside Cambodian forests
por: Kunkel, Amber, et al.
Publicado: (2021)

Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency
por: Kheng, Sim, et al.
Publicado: (2015)

Efficacy of Single-Dose Primaquine With Artemisinin Combination Therapy on Plasmodium falciparum Gametocytes and Transmission: An Individual Patient Meta-Analysis
por: Stepniewska, Kasia, et al.
Publicado: (2020)

Performance of the CareStart™ G6PD Deficiency Screening Test, a Point-of-Care Diagnostic for Primaquine Therapy Screening
por: Kim, Saorin, et al.
Publicado: (2011)

Sustained Ex Vivo Susceptibility of Plasmodium falciparum to Artemisinin Derivatives but Increasing Tolerance to Artemisinin Combination Therapy Partner Quinolines in The Gambia
por: Amambua-Ngwa, Alfred, et al.
Publicado: (2017)

Performance of Ultrasensitive Rapid Diagnostic Tests for Detecting Asymptomatic Plasmodium falciparum
por: Yeung, Shunmay, et al.
Publicado: (2020)

Evidence of successful malaria case management policy implementation in Cambodia: results from national ACTwatch outlet surveys
por: Novotny, Joe, et al.
Publicado: (2016)

Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria
por: Taylor, Walter Robert, et al.
Publicado: (2021)

Plasmodium knowlesi Infection in Humans, Cambodia, 2007–2010
por: Khim, Nimol, et al.
Publicado: (2011)

Evolution of Multidrug Resistance in Plasmodium falciparum: a Longitudinal Study of Genetic Resistance Markers in the Greater Mekong Subregion
por: Imwong, Mallika, et al.
Publicado: (2021)

Mutation in the Plasmodium falciparum BTB/POZ Domain of K13 Protein Confers Artemisinin Resistance
por: Paloque, Lucie, et al.
Publicado: (2022)

Mobility evaluation by GPS tracking in a rural, low-income population in Cambodia
por: Pepey, Anaïs, et al.
Publicado: (2022)

Spatial clustering and risk factors of malaria infections in Ratanakiri Province, Cambodia
por: Sluydts, Vincent, et al.
Publicado: (2014)

Acute Undifferentiated Febrile Illness in Rural Cambodia: A 3-Year Prospective Observational Study
por: Mueller, Tara C., et al.
Publicado: (2014)

Cost of increasing access to artemisinin combination therapy: the Cambodian experience
por: Yeung, Shunmay, et al.
Publicado: (2008)

An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia
por: Leang, Rithea, et al.
Publicado: (2016)

Erratum to: An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia
por: Leang, Rithea, et al.
Publicado: (2016)

Clinical and In Vitro Resistance of Plasmodium falciparum to Artesunate-Amodiaquine in Cambodia
por: Mairet-Khedim, Melissa, et al.
Publicado: (2020)

Effects of liver-stage clearance by Primaquine on gametocyte carriage of Plasmodium vivax and P. falciparum
por: Wampfler, Rahel, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_afnlfo0aib4q455ngn2lhmo3hc